Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1992;126(1):271–281. doi: 10.1007/BF01309700

Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies

J Arikawa 1, J -S Yao 2, K Yoshimatsu 1, I Takashima 2, N Hashimoto 2
PMCID: PMC7087150  PMID: 1381911

Summary

To investigate the role of Hantaan virus envelope glycoprotein in infection, a panel of monoclonal antibodies (MAbs) was examined in vitro with several serological tests and in vivo by passive transfer experiments in mice. An antigenic site, specific for the inhibition of infected cell focus was detected with the focus inhibition neutralization test (FINT), in addition to the neutralization related antigenic sites, which were revealed by the ordinary focus reduction neutralization test (FRNT). Suckling mice were given the MAbs by passive transfer followed by lethal Hantaan virus challenge. All neutralizing MAbs detected by either FRNT or FINT protected all mice from lethal infection, confirming the importance of the antigenic sites as a protective antigen. Mice given non-neutralizing MAbs by passive transfer, however, began to die earlier than the control group; mean time to death (18.2±2.1 to 21.5±2.8 days) being significantly shorter than that of the control group (25.8±1.8, p<0.01, Mann-Whitney,U probability test). Virus titers in brains of mice which died early, were about 10 times higher than those of control mice. These results indicated the early death phenomenon of mice which was mediated by the antivirus antibody.

Keywords: Virus Titer, Probability Test, Early Death, Envelope Protein, Virus Envelope

References

  • 1.Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol. 1989;70:615–624. doi: 10.1099/0022-1317-70-3-615. [DOI] [PubMed] [Google Scholar]
  • 2.Arikawa J, Takashima I, Hashimoto N. Cell fusion by haemorrhagic fever with renal syndrome (HFRS) viruses and its application for titration of virus infectivity and neutralization antibody. Arch Virol. 1985;86:303–313. doi: 10.1007/BF01309834. [DOI] [PubMed] [Google Scholar]
  • 3.Arikawa J, Takashima I, Hashimoto N, Takahashi K, Yagi K, Hattori K. Epidemiological studies of hemorrhagic fever with renal syndrome (HFRS) related virus infection among urban rats in Hokkaido, Japan. Arch Virol. 1986;88:231–240. doi: 10.1007/BF01310877. [DOI] [PubMed] [Google Scholar]
  • 4.Fanko MC, Gibbs CJ, Jr, Lee PW, Gajdusek DC. Monoclonal antibodies specific for hantaan virus. Proc Natl Acad Sci USA. 1983;80:4149–4153. doi: 10.1073/pnas.80.13.4149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gould EA, Buckley A. Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence. J Gen Virol. 1989;70:1605–1608. doi: 10.1099/0022-1317-70-6-1605. [DOI] [PubMed] [Google Scholar]
  • 6.Gould EA, Buckley A, Groeger BK, Cane PA, Doenhoff M. Immune enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms involved. J Gen Virol. 1987;68:3105–3112. doi: 10.1099/0022-1317-68-12-3105. [DOI] [PubMed] [Google Scholar]
  • 7.Grosfeld H, Velan B, Leitner M, Cohen S, Lustig S, Lachmi BE, Shafferman A. Semliki forest virus E2 envelope epitopes induce a non-neutralizing humoral response which protects mice against lethal challenge. J Virol. 1989;63:3416–3422. doi: 10.1128/jvi.63.8.3416-3422.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jiang YT. A preliminary report on hemorrhagic fever with renal syndrome in China. Chinese Med J. 1983;96:265–268. [PubMed] [Google Scholar]
  • 9.Kim GR, McKee KT., Jr Pathogenesis of hantaan virus infection in suckling mice: clinical, virologic and serologic observations. Am J Trop Med Hyg. 1985;34:388–395. doi: 10.4269/ajtmh.1985.34.388. [DOI] [PubMed] [Google Scholar]
  • 10.Lähdevirta J, Savola J, Brummer-Korvenkontio M, Berndt R, Illikainen R, Vaheri A. Clinical and serological diagnosis of Nephropathia epidemica, the mild type of hemorrhagic fever with renal syndrome. J Infect Dis. 1984;9:230–238. doi: 10.1016/s0163-4453(84)90464-x. [DOI] [PubMed] [Google Scholar]
  • 11.Lee HW, Lee PW, Baek LJ, Chu YK. Seroepidemiological features of haemorrhagic fever with renal syndrome in the Republic of Korea from 1980 to 1987. JE HFRS Bull. 1989;3:45–48. [Google Scholar]
  • 12.Lee HW, Lee PW, Baek LJ, Chu YK. Geographical distribution of hemorrhagic fever with renal syndrome and hantaviruses. Arch Virol. 1990;1(Suppl):5–18. [Google Scholar]
  • 13.Lee HW, Lee PW, Johnson KM. Isolation of the etiological agent, Korean hemorrhagic fever. J Infect Dis. 1978;137:298–308. doi: 10.1093/infdis/137.3.298. [DOI] [PubMed] [Google Scholar]
  • 14.McLain L, Dimmock NJ. Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus. J Gen Virol. 1989;70:2615–2624. doi: 10.1099/0022-1317-70-10-2615. [DOI] [PubMed] [Google Scholar]
  • 15.Myasnikov YuA, Rezapkin GV, Shuikova ZV, Tkachenko EA, Ivanova AA, Nurgaleeva RG, Stepanenko AG, Vereshchagin NN, Loginov AI, Bagan RN, Zaitseva AA, Levacheva ZA, Bobylkova TV, Ishcheryakova AM, Boruta VV. Antibodies to the HFRS virus in the human population of European RSFSR as detected by radioimmunoassay. Arch Virol. 1984;79:109–115. doi: 10.1007/BF01314308. [DOI] [PubMed] [Google Scholar]
  • 16.Nagai T, Tanishita O, Takahashi Y, Yamanouchi T, Domae K, Kondo K, Dantas JR, Jr, Takahashi M, Yamanishi K. Isolation of hemorrhagic fever with renal syndrome virus from leukocyte of rats and virus replication in cultures of rat and human macrophages. J Gen Virol. 1985;66:1271–1278. doi: 10.1099/0022-1317-66-6-1271. [DOI] [PubMed] [Google Scholar]
  • 17.Nakamura T, Yanagihara R, Gibbs JC, Jr, Amyx LH, Gajdusek CD. Different susceptibility and resistance of immunocompetent and immunodeficient mice to fatal hantaan virus infection. Arch Virol. 1985;86:109–120. doi: 10.1007/BF01314117. [DOI] [PubMed] [Google Scholar]
  • 18.Nakamura T, Yanagihara R, Gibbs CJ, Jr, Gajdusek CD. Immune spleen cell-mediated protection against fatal hantaan virus infection in infant mice. J Infect Dis. 1985;151:691–697. doi: 10.1093/infdis/151.4.691. [DOI] [PubMed] [Google Scholar]
  • 19.Prabhakar BS, Nathanson N. Acute rabies death mediated by antibody. Nature. 1981;290:590–591. doi: 10.1038/290590a0. [DOI] [PubMed] [Google Scholar]
  • 20.Putnak RJ, Schlesinger JJ. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b. J Gen Virol. 1990;71:1697–1702. doi: 10.1099/0022-1317-71-8-1697. [DOI] [PubMed] [Google Scholar]
  • 21.Schlesinger JJ, Brandriss MW, Putnak JR, Walsh EE. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. J Gen Virol. 1990;71:593–599. doi: 10.1099/0022-1317-71-3-593. [DOI] [PubMed] [Google Scholar]
  • 22.Schlesinger JJ, Brandriss MW, Walsh EE. Protection of mice against Dengue 2 virus encephalitis by immunization with the dengue 2 virus nonstructural glycoprotein NS1. J Gen Virol. 1987;68:853–857. doi: 10.1099/0022-1317-68-3-853. [DOI] [PubMed] [Google Scholar]
  • 23.Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol. 1990;64:3162–3170. doi: 10.1128/jvi.64.7.3162-3170.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Schmaljohn CS, Dalrymple JM. Analysis of Hantaan virus RNA: evidence for a new genus of Bunyaviridae. Virology. 1983;131:482–491. doi: 10.1016/0042-6822(83)90514-7. [DOI] [PubMed] [Google Scholar]
  • 25.Schmaljohn CS, Hasty SE, Harrison SA, Dalrymple JM. Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome. J Infect Dis. 1983;148:1005–1012. doi: 10.1093/infdis/148.6.1005. [DOI] [PubMed] [Google Scholar]
  • 26.Schmaljohn AL, Johnson ED, Dalrymple JM, Cole GA. Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature. 1982;297:70–72. doi: 10.1038/297070a0. [DOI] [PubMed] [Google Scholar]
  • 27.Song G, Hang CS, Liao HX, Fu JL, Gao GZ, Qiu HL, Zhang QF. Antigenic difference between viral strains causing classical and mild types of epidemic hemorrhagic fever with renal syndrome in China. J Infect Dis. 1984;150:889–894. doi: 10.1093/infdis/150.6.889. [DOI] [PubMed] [Google Scholar]
  • 28.Tamura M, Asada H, Kondo K, Tanishita O, Kurata T, Yamanishi K. Pathogenesis of hantaan virus in mice. J Gen Virol. 1989;70:2897–2906. doi: 10.1099/0022-1317-70-11-2897. [DOI] [PubMed] [Google Scholar]
  • 29.Tan CHc, Yap EH, Singh M, Deubel V, Chan YC. Passive protection studies in mice with monoclonal antibodies directed against the nonstructural protein NS3 of dengue 1 virus. J Gen Virol. 1990;71:745–748. doi: 10.1099/0022-1317-71-3-745. [DOI] [PubMed] [Google Scholar]
  • 30.Tanishita O, Takahashi Y, Okuno Y, Yamanishi K, Takahashi M. Evaluation of focus reduction neutralization test with peroxidase-antiperoxidase staining technique for hemorrhagic fever with renal syndrome virus. J Clin Microbiol. 1984;20:1213–1215. doi: 10.1128/jcm.20.6.1213-1215.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Umino Y, Kohama T, Sato A, Sugiura A. Protective effect of monoclonal antibodies to Newcastle disease virus in passive immunization. J Gen Virol. 1990;71:1199–1203. doi: 10.1099/0022-1317-71-5-1199. [DOI] [PubMed] [Google Scholar]
  • 32.Webb HE, Wight DGD, Platt GS, Smith CEG. Langat virus encephalitis in mice. I. The effect of the administration of specific antiserum. J Hyg. 1968;66:343–354. doi: 10.1017/s0022172400041218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Weiss RC, Scott FW. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immun Microbiol Infect Dis. 1981;4:175–189. doi: 10.1016/0147-9571(81)90003-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.World Health Organization Hemorrhagic fever with renal syndrome: memorandum from a WHO meeting. Bull WHO. 1983;61:269–275. [PMC free article] [PubMed] [Google Scholar]
  • 35.Yanagihara R, Gajdusek CD. Hemorrhagic fever with renal syndrome: Global epidemiology and ecology of hantavirus infections. Med Virol. 1987;6:198–202. [Google Scholar]
  • 36.Yao JS, Kariwa H, Takashima I, Arikawa J, Hashimoto N. Antibody-dependent enhancement of hantavirus infection in macrophage cell lines. Arch Virol. 1991;122:107–118. doi: 10.1007/BF01321121. [DOI] [PubMed] [Google Scholar]
  • 37.Zhang XK, Takashima I, Mori F, Hashimoto N. Comparison of virulence between two strains ofRattus serotype hemorrhagic fever with renal syndrome (HFRS) virus in newborn rats. Microbiol Immunol. 1989;33:195–205. doi: 10.1111/j.1348-0421.1989.tb01513.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

RESOURCES